5-L-hydroxy-6,8,11,14-eicosatetraenoate potentiates the human neutrophil degranulating action of platelet-activating factor

Biochemical and Biophysical Research Communications
J T O'FlahertyR L Wykle

Abstract

Platelet-activating factor (AAGPC) and two of its structural analogues degranulated human neutrophils with respective potencies that were increased up to 100 to 1000-fold by 16 nM to 5 microM of 5-L-hydroxyeicosatetraenoate (5-L-HETE). 5-rac-HETE had similar actions but 8-rac-HETE was without effect. Furthermore, 5-L-HETE did not influence the degranulating actions of C5a, A23187 or a formalated oligopeptide chemotactic factor and none of the HETEs, by themselves, caused degranulation. Thus, 5-L-HETE and AAGPC selectively interact to induce degranulation. Since these products rapidly form in stimulated PMNs, they may serve as potentiator and agonist, respectively, to transduce biological signals into cell function.

Citations

Feb 29, 1988·Clinica Chimica Acta; International Journal of Clinical Chemistry·N TatsumiT Kyougoku
Feb 1, 1985·Prostaglandins, Leukotrienes, and Medicine·J T O'Flaherty, M J Thomas
Feb 1, 1993·Experimental Dermatology·B GrønK Kragballe
Oct 1, 1990·Prostaglandins, Leukotrienes, and Essential Fatty Acids·T RadeauP H Godard
Oct 1, 2011·Lipids in Health and Disease·Isis T SilvaNágila R T Damasceno
Mar 29, 1985·Biochemical and Biophysical Research Communications·J T O'FlahertyR L Wykle
Nov 21, 1988·FEBS Letters·A G RossiJ T O'Flaherty
Mar 6, 2004·Pharmacological Reviews·Charles BrinkTakehiko Yokomizo
Feb 15, 1987·Biochemical Pharmacology·J T O'Flaherty
Jan 1, 1988·Progress in Lipid Research·A A SpectorS A Moore
Jan 1, 1989·Archives of Oral Biology·K NoguchiS Murota
Oct 1, 1990·Prostaglandins, Leukotrienes, and Essential Fatty Acids·P V Peplow, D P Mikhailidis
Aug 1, 1995·Prostaglandins, Leukotrienes, and Essential Fatty Acids·E J Bates
Aug 30, 1984·Biochemical and Biophysical Research Communications·J T O'FlahertyR L Wykle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.